Mapping the Resistance Potential of Influenza’s H + Channel Using an Anti
DOI:
https://doi.org/10.59415/ijfas.v6i4.112Keywords:
Influenza A virus, Influenza M2 protein, adamantineAbstract
One of the biggest problems faced by biotechnologists and pharmacologists all over the world is the difficulty in predicting the strains of viral diseases that are coming into circulation. The problem becomes much worse when it becomes difficult to predict the virus’s resistance pattern.
Influenza A virus has many factors that play a role in its infection cycle. Here, we are trying to study how the virus exhibits resistance against an anti-viral blocker.
The blocker that is used in this case is amino-adamantane antiviral inhibitor (adamantine).
Published
Issue
Section
License
Copyright (c) 2022 International Journal of Fundamental and Applied Sciences (IJFAS)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
License Statement
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors who publish with International Journal of Fundamental and Applied Sciences (IJFAS) retain copyright of their articles and grant the journal the right of first publication.
This license allows others to share, use, and build upon the work—commercially or non-commercially—as long as appropriate credit is given to the original authors and source, and any changes are indicated.
The journal encourages open access and supports the free exchange of knowledge while ensuring proper attribution of original work.
